Innovations in cardiac arrhythmia monitoring devices leading to the introduction of novel, convenient and wearable devices will pave the way for the market expansion. Existing and new industry participants are focusing on developing small, light-weight and patient-friendly devices that facilitate remote monitoring of patient's cardiac indicators. In June 2019, Zoll Medical announced the launch of Zoll HFAMS, a patch-based wearable heart management system that is designed to manage heart rhythm, respiratory rate, and heart rate with several other functions. Such innovations will increase customer preference, further impacting market growth.

The mobile cardiac telemetry segment is poised to witness over an 8% growth rate through 2026 due to rapidly increasing investment in mobile cardiac telemetry devices offering superior features compared to traditional monitoring devices. Mobile cardiac telemetry devices detect asymptomatic, as well as symptomatic, arrhythmias. Besides, these devices allow unrestricted movement and wirelessly transmit cardiac data in real time.

The tachycardia application segment dominated around 87% of the cardiac arrhythmia monitoring devices market share in 2019. Tachycardia is an anomaly in heart rhythm wherein the heart beats at a faster pace than normal. To diagnose a specific type of tachycardia and for proper disease management, healthcare professionals recommend monitoring devices such as ECG devices, Holter monitors, event recorders or other portable monitors.

The home care setting's segment size in the cardiac arrhythmia monitoring devices market is predicted to reach USD 950 million by 2026, led by growing awareness about remote patient monitoring devices in developing countries. Additionally, increasing availability and penetration of companies manufacturing wearable cardiac devices that enable continuous monitoring even at home drives customer preference.

Europe's cardiac arrhythmia monitoring devices market valuation was more than USD 1.7 billion in 2019 on account of the growing geriatric patient pool and the presence of prominent industry players. Also, the rising pervasiveness of chronic heart disorders owing to increasing obesity and the adoption of smoking will influence the demand for monitoring devices. Moreover, the increasing number of COVID-19 patients requiring remote monitoring of cardiac parameters will propel the European industry.

Media Contact
John Mathews
Journal Manager
Current Trends in Cardiology
Email: cardiologyres@eclinicalsci.com